logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
P

Philip O. Buck

modernatx, inc.

27H-index
129Paper Count
3.5KCitation Count
Published Papers 40
Publication Date
logo
Economic Burden of Congenital Cytomegalovirus Disease on Families in the United States
errViruses-Basel
IF3.5
err2026-09-07
err0
errOAAI
errPhilip O. Buck; Carolyn Sweeney; Mihaela Georgieva; Colin Kunzweiler; Harout Tossonian; Kimberly Boyle; Costel Chirila; Rebecca Crawford; Sorrel Wolowacz; Megan H. Pesch
errShare
errSave
Retrospective claims analysis of the epidemiology and economic burden of diagnosed congenital cytomegalovirus in Japan
errCURRENT MEDICAL RESEARCH AND OPINION
IF2.2
err2025-09-01
err0
PREAI
errBuck, Philip O.; Goldschmidt, Debbie; Anderson, Annika; Kirson, Noam; Desai, Urvi; Diaz-Decaro, John
errShare
errSave
Response to Letter Regarding Article “Epidemiology and Economic Burden of Diagnosed Congenital Cytomegalovirus Infection in the First 2 Years of Life among Commercially Insured and Medicaid-Insured Individuals in the United States”
errClinical Therapeutics
IF3.6
err2025-06-26
err0
PREAI
errJohn Diaz-Decaro; Philip O. Buck
errShare
errSave
Epidemiology and Economic Burden of Diagnosed Congenital Cytomegalovirus Infection in the First 2 Years of Life among Commercially Insured and Medicaid-Insured Individuals in the United States
errCLINICAL THERAPEUTICS
IF3.6
err2025-06-01
err0
errOAAI
errJohn Diaz-Decaro; Gail J. Demmler-Harrison; Jessica R. Marden; Annika Anderson; Sandeep Basnet; Katherine Gaburo; Noam Kirson; Urvi Desai; Philip O. Buck
errShare
errSave
Population-Based Incidence of Infectious Mononucleosis and Related Hospitalizations: 2010 Through 2021
errMayo Clinic Proceedings
IF6.7
err2025-03-07
err0
PREAI
errJennifer L. St. Sauver; Robert M. Jacobson; Susan A. Weston; Chun Fan; Philip O. Buck; Susan A. Hall
errShare
errSave
US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines
errJOURNAL OF MEDICAL ECONOMICS
IF3
err2025-02-20
err0
errOAAI
errChristine Poulos; Philip O. Buck; Parinaz Ghaswalla; Deborah Rudin; Cannon Kent; Darshan Mehta
errShare
errSave
New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement
errVACCINES
IF3.4
err2024-02-24
err0
errOAAI
errBuck, Philip O.; Gomes, Dumingu Aparna; Beck, Ekkehard; Kirson, Noam; Mattera, Matthew; Carroll, Stuart; Ultsch, Bernhard; Jayasundara, Kavisha; Uhart, Mathieu; Garrison, Louis P.
errShare
errSave
Relative Effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines and Homologous Boosting in Preventing COVID-19 in Adults in the US
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2023-05-25
err15
errOAAI
errHung Nguyen, Van; Boileau, Catherine; Bogdanov, Alina; Sredl, Meg; Bonafede, Mac; Ducruet, Thierry; Chavers, Scott; Rosen, Andrew; Martin, David; Buck, Philip; Esposito, Daina; van de Velde, Nicolas; Mansi, James A.
errShare
errSave
Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers' attitudes and practices
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2022-10-26
err4
errOAAI
errHerrera-Restrepo, Oscar; Davis, Kimberly; Sweeney, Carolyn; Davenport, Eric; Ghaswalla, Parinaz; Buck, Philip O.
errShare
errSave
A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development
errBMC PUBLIC HEALTH
IF3.6
err2022-09-01
err103
errOAAI
errFowler, Karen; Mucha, Jacek; Neumann, Monika; Lewandowski, Witold; Kaczanowska, Magdalena; Grys, Maciej; Schmidt, Elvira; Natenshon, Andrew; Talarico, Carla; Buck, Philip O.; Diaz-Decaro, John
errShare
errSave
The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program
errVACCINES
IF3.4
err2022-01-18
err5
errOAAI
errShiri, Tinevimbo; Evans, Marc; Talarico, Carla A.; Morgan, Angharad R.; Mussad, Maaz; Buck, Philip O.; McEwan, Phil; Strain, William David
errShare
errSave
Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example
errVACCINES
IF3.4
err2021-10-15
err17
errOAAI
errShiri, Tinevimbo; Evans, Marc; Talarico, Carla A.; Morgan, Angharad R.; Mussad, Maaz; Buck, Philip O.; McEwan, Phil; Strain, William David
errShare
errSave
Time and cost of administering COVID-19 mRNA vaccines in the United States
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2021-10-06
err4
errOAAI
errYarnoff, Benjamin; Bodhaine, Steven; Cohen, Ed; Buck, Philip O.
errShare
errSave
Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2021-04-13
err24
errOAAI
errPatterson, Brandon J.; Chen, Chi-Chang; McGuiness, Catherine B.; Glasser, Lisa I.; Sun, Kainan; Buck, Philip O.
errShare
errSave
Correspondence regarding Wilson et al., cost-effectiveness of a comprehensive immunization program serving high-risk, uninsured adults
errPREVENTIVE MEDICINE
IF3.2
err2020-04-01
err0
errOAAI
errPatterson, Brandon J.; Curran, Desmond; Buck, Philip O.
errShare
errSave
Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2020-02-20
err2
errOAAI
errHsiao, Amber; Buck, Philip O.; Yee, Arnold; Hansen, John; Lewis, Edwin M.; Aukes, Laurie L.; Yanni, Emad; Bekkat-Berkani, Rafik; Schuind, Anne; Klein, Nicola P.
errShare
errSave
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2019-11-22
err8
errOAAI
errStandaert, Baudouin; Van Vlaenderen, Ilse; Van Bellinghen, Laure-Anne; Talbird, Sandra; Hicks, Katherine; Carrico, Justin; Buck, Philip O.
errShare
errSave
Maternal Immunization in the US: A Nationwide Retrospective Cohort Study
errAMERICAN JOURNAL OF PREVENTIVE MEDICINE
IF4.5
err2019-09-01
err28
errOAAI
errGhaswalla, Parinaz; Poirrier, Jean-Etienne M.; Packnett, Elizabeth R.; Irwin, Debra E.; Gray, Stephanie R.; Buck, Philip O.
errShare
errSave
Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physicians
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2019-03-20
err7
errOAAI
errMcNamara, Michelle; Buck, Philip O.; Yan, Songkai; Friedland, Leonard R.; Lerch, Kristin; Murphy, Alysa; Hogea, Cosmina
errShare
errSave
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2019-02-20
err16
errOAAI
errCurran, Desmond; Patterson, Brandon J.; Van Oorschot, Desiree; Buck, Philip O.; Carrico, Justin; Hicks, Katherine A.; Lee, Bruce; Yawn, Barbara P.
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
S
Stephen P. Peters
H-index: 97 · Papers: 546
C
Cathérine Boileau
H-index: 86 · Papers: 479
B
Barbara P. Yawn
H-index: 84 · Papers: 464
B
Bruce L. Innis
H-index: 74 · Papers: 265
N
Nicola P. Klein
H-index: 72 · Papers: 441
View more